Frontiers in Cancer Research
Nova Publishers, 2006 - 256 páginas
Cancer is a group of different diseases (over 100) characterised by uncontrolled growth and spread of abnormal cells. Cancer can arise in many sites and behave differently depending on its organ of origin. If a cancer spreads (metastasises), the new tumour bears the same name as the original (primary) tumour. Significant progress has been made in recent years in the battle against cancer and in understanding its underlying biological mechanisms. This research progress has resulted in many experimental treatments and cures which establish hope for wide-spread cures. This book brings together important research from around the world in this frontal field.
Comentarios de usuarios - Escribir una reseña
No hemos encontrado ninguna reseña en los sitios habituales.
Craniomaxillofacial Resection for Advanced Oral and Maxillofacial Tumors
FasResistance in Adult TCell Leukemia Lymphoma
Cranial Prophylaxis in NonHodgkins Lymphoma
Clinical Significance of PGlycoprotein in Acute Leukemia and a Strategy to Overcome Drug Resistance
Quality of Life of Metastatic Renal Carcinoma Patients Receiving Subcutaneous Interferon or Intravenous Interleukin2
Control of BCLL Apoptosis by Members of the TNF Superfamily
Surgical Management of Advanced Primary and Recurrent Ovarian Cancer The Washington Cancer Institute Approach
The Clinical Value of Static DNA Cytometry in the Diagnosis Prognosis and Therapy of Prostate and Bladder Cancer
abnormalities activation acute leukemia acute lymphoblastic leukemia acute myeloid leukemia analysis antibody antigen antisense apoptosis autocrine B-CLL cells B-CLL patients BAFF and APRIL bone marrow carcinoma caspase chronic lymphocytic leukemia Clin clinical correlation craniofacial resection craniomaxillofacial resection cytogenetic cytokines cytoreduction detected diagnosis differentiation drug evaluation flap flow cytometry foramen gene Haematol HLA-DR Immunol immunophenotype immunophenotypic profile induced inhibits interleukin-2 intracellular intraperitoneal chemotherapy involvement Leuk leukemic blast cells leukemic cells levels ligand lineage lymphoid malignant markers mdr1 MDR1-AS mFas middle cranial fossa minimal residual disease molecules mRNA multidrug resistance mutations NF-kB non-Hodgkin’s lymphoma normal oligonucleotides Oncol ovarian cancer P-gp expression P-gp positive peritoneal peritonectomy phenotype prognostic proliferation protein receptor relapse reported role sensitivity serum signal significantly sinus skull base soluble stemline subtypes surgery surgical survival survivin T-ALL therapy tissues TNF-o transcripts treatment tumor cells tumor necrosis factor vitro